Advisers to the Food and Drug Administration voted Thursday to back a plan whereby all Covid vaccines would move to the formulation used for the updated boosters, a step toward the goal of creating a single annual Covid shot for most Americans.
The panel said that a single vaccine would both be more effective and less confusing to both patients and health care workers.